![]()
2024 ASCO Annual Meeting
2024 ASCO Annual Meeting
Oral Abstract Session
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
June 1 – 3:00 PM CDT
location_onHall D1
2024 ASCO Annual Meeting
Rapid Oral Abstract Session
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
June 3 – 8:00 AM CDT
location_onS406
Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial.
8:12 AM CDTJia (Jenny) Liu, MD, PhDAbstract 3014
- Forums
- ASX - By Stock
- SPL
- ASCO Presentations 2024
SPL
starpharma holdings limited
Add to My Watchlist
0.00%
!
12.0¢

ASCO Presentations 2024
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.18M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 12.0¢ | $55 | 461 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 215514 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 19539 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 215514 | 0.115 |
5 | 134099 | 0.110 |
3 | 146900 | 0.105 |
6 | 563009 | 0.100 |
1 | 30303 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 19539 | 1 |
0.125 | 76806 | 1 |
0.130 | 323620 | 3 |
0.135 | 230549 | 8 |
0.140 | 155336 | 3 |
Last trade - 11.27am 15/09/2025 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
FBM
FUTURE BATTERY MINERALS LIMITED
Nick Rathjen, MD & CEO
Nick Rathjen
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online